285 related articles for article (PubMed ID: 35213359)
1. Predicting pancreatic ductal adenocarcinoma using artificial intelligence analysis of pre-diagnostic computed tomography images.
Qureshi TA; Gaddam S; Wachsman AM; Wang L; Azab L; Asadpour V; Chen W; Xie Y; Wu B; Pandol SJ; Li D
Cancer Biomark; 2022; 33(2):211-217. PubMed ID: 35213359
[TBL] [Abstract][Full Text] [Related]
2. Risk prediction of pancreatic cancer using AI analysis of pancreatic subregions in computed tomography images.
Javed S; Qureshi TA; Gaddam S; Wang L; Azab L; Wachsman AM; Chen W; Asadpour V; Jeon CY; Wu B; Xie Y; Pandol SJ; Li D
Front Oncol; 2022; 12():1007990. PubMed ID: 36439445
[TBL] [Abstract][Full Text] [Related]
3. Utility of CT Radiomics Features in Differentiation of Pancreatic Ductal Adenocarcinoma From Normal Pancreatic Tissue.
Chu LC; Park S; Kawamoto S; Fouladi DF; Shayesteh S; Zinreich ES; Graves JS; Horton KM; Hruban RH; Yuille AL; Kinzler KW; Vogelstein B; Fishman EK
AJR Am J Roentgenol; 2019 Aug; 213(2):349-357. PubMed ID: 31012758
[No Abstract] [Full Text] [Related]
4. Radiomics-based Machine-learning Models Can Detect Pancreatic Cancer on Prediagnostic Computed Tomography Scans at a Substantial Lead Time Before Clinical Diagnosis.
Mukherjee S; Patra A; Khasawneh H; Korfiatis P; Rajamohan N; Suman G; Majumder S; Panda A; Johnson MP; Larson NB; Wright DE; Kline TL; Fletcher JG; Chari ST; Goenka AH
Gastroenterology; 2022 Nov; 163(5):1435-1446.e3. PubMed ID: 35788343
[TBL] [Abstract][Full Text] [Related]
5. Computerized tomography scan in pre-diagnostic pancreatic ductal adenocarcinoma: Stages of progression and potential benefits of early intervention: A retrospective study.
Singh DP; Sheedy S; Goenka AH; Wells M; Lee NJ; Barlow J; Sharma A; Kandlakunta H; Chandra S; Garg SK; Majumder S; Levy MJ; Takahashi N; Chari ST
Pancreatology; 2020 Oct; 20(7):1495-1501. PubMed ID: 32950386
[TBL] [Abstract][Full Text] [Related]
6. Validation of Prognostic Radiomic Features From Resectable Pancreatic Ductal Adenocarcinoma in Patients With Advanced Disease Undergoing Chemotherapy.
Salinas-Miranda E; Khalvati F; Namdar K; Deniffel D; Dong X; Abbas E; Wilson JM; O'Kane GM; Knox J; Gallinger S; Haider MA
Can Assoc Radiol J; 2021 Nov; 72(4):605-613. PubMed ID: 33151087
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of unenhanced CT texture analysis to differentiate mass-forming pancreatitis from pancreatic ductal adenocarcinoma.
Ren S; Zhao R; Zhang J; Guo K; Gu X; Duan S; Wang Z; Chen R
Abdom Radiol (NY); 2020 May; 45(5):1524-1533. PubMed ID: 32279101
[TBL] [Abstract][Full Text] [Related]
8. Automated Artificial Intelligence Model Trained on a Large Data Set Can Detect Pancreas Cancer on Diagnostic Computed Tomography Scans As Well As Visually Occult Preinvasive Cancer on Prediagnostic Computed Tomography Scans.
Korfiatis P; Suman G; Patnam NG; Trivedi KH; Karbhari A; Mukherjee S; Cook C; Klug JR; Patra A; Khasawneh H; Rajamohan N; Fletcher JG; Truty MJ; Majumder S; Bolan CW; Sandrasegaran K; Chari ST; Goenka AH
Gastroenterology; 2023 Dec; 165(6):1533-1546.e4. PubMed ID: 37657758
[TBL] [Abstract][Full Text] [Related]
9. CT Radiomics-Based Preoperative Survival Prediction in Patients With Pancreatic Ductal Adenocarcinoma.
Park S; Sham JG; Kawamoto S; Blair AB; Rozich N; Fouladi DF; Shayesteh S; Hruban RH; He J; Wolfgang CL; Yuille AL; Fishman EK; Chu LC
AJR Am J Roentgenol; 2021 Nov; 217(5):1104-1112. PubMed ID: 34467768
[No Abstract] [Full Text] [Related]
10. Quantitative Radiomic Features From Computed Tomography Can Predict Pancreatic Cancer up to 36 Months Before Diagnosis.
Chen W; Zhou Y; Asadpour V; Parker RA; Puttock EJ; Lustigova E; Wu BU
Clin Transl Gastroenterol; 2023 Jan; 14(1):e00548. PubMed ID: 36434803
[TBL] [Abstract][Full Text] [Related]
11. An Automated Prognostic Model for Pancreatic Ductal Adenocarcinoma.
Vezakis I; Vezakis A; Gourtsoyianni S; Koutoulidis V; Polydorou AA; Matsopoulos GK; Koutsouris DD
Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761882
[TBL] [Abstract][Full Text] [Related]
12. Radiomics model-based algorithm for preoperative prediction of pancreatic ductal adenocarcinoma grade.
Tikhonova VS; Karmazanovsky GG; Kondratyev EV; Gruzdev IS; Mikhaylyuk KA; Sinelnikov MY; Revishvili AS
Eur Radiol; 2023 Feb; 33(2):1152-1161. PubMed ID: 35986774
[TBL] [Abstract][Full Text] [Related]
13. Artificial intelligence for assessment of vascular involvement and tumor resectability on CT in patients with pancreatic cancer.
Bereska JI; Janssen BV; Nio CY; Kop MPM; Kazemier G; Busch OR; Struik F; Marquering HA; Stoker J; Besselink MG; Verpalen IM;
Eur Radiol Exp; 2024 Feb; 8(1):18. PubMed ID: 38342782
[TBL] [Abstract][Full Text] [Related]
14. Radiomic feature reproducibility in contrast-enhanced CT of the pancreas is affected by variabilities in scan parameters and manual segmentation.
Yamashita R; Perrin T; Chakraborty J; Chou JF; Horvat N; Koszalka MA; Midya A; Gonen M; Allen P; Jarnagin WR; Simpson AL; Do RKG
Eur Radiol; 2020 Jan; 30(1):195-205. PubMed ID: 31392481
[TBL] [Abstract][Full Text] [Related]
15. Artificial intelligence to predict T4 stage of pancreatic ductal adenocarcinoma using CT imaging.
Miao Q; Wang X; Cui J; Zheng H; Xie Y; Zhu K; Chai R; Jiang Y; Feng D; Zhang X; Shi F; Tan X; Fan G; Liang K
Comput Biol Med; 2024 Mar; 171():108125. PubMed ID: 38340439
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance of commercially available vs. in-house radiomics software in classification of CT images from patients with pancreatic ductal adenocarcinoma vs. healthy controls.
Chu LC; Solmaz B; Park S; Kawamoto S; Yuille AL; Hruban RH; Fishman EK
Abdom Radiol (NY); 2020 Aug; 45(8):2469-2475. PubMed ID: 32372206
[TBL] [Abstract][Full Text] [Related]
17. Radiomics model of dual-time 2-[
Liu Z; Li M; Zuo C; Yang Z; Yang X; Ren S; Peng Y; Sun G; Shen J; Cheng C; Yang X
Eur Radiol; 2021 Sep; 31(9):6983-6991. PubMed ID: 33677645
[TBL] [Abstract][Full Text] [Related]
18. CT Abnormalities of the Pancreas Associated With the Subsequent Diagnosis of Clinical Stage I Pancreatic Ductal Adenocarcinoma More Than 1 Year Later: A Case-Control Study.
Toshima F; Watanabe R; Inoue D; Yoneda N; Yamamoto T; Sasahira N; Sasaki T; Matsuyama M; Minehiro K; Tateishi U; Gabata T
AJR Am J Roentgenol; 2021 Dec; 217(6):1353-1364. PubMed ID: 34161128
[No Abstract] [Full Text] [Related]
19. Determining age and sex-specific distribution of pancreatic whole-gland CT attenuation using artificial intelligence aided image segmentation: Associations with body composition and pancreatic cancer risk.
Janssens LP; Weston AD; Singh D; Spears G; Harmsen WS; Takahashi N; Philbrick KA; Erickson BJ; Abu Dayyeh BK; Chari ST; Chandrasekhara V; Gleeson FC; Levy MJ; Pearson RK; Petersen BT; Vege SS; Majumder S
Pancreatology; 2021 Dec; 21(8):1524-1530. PubMed ID: 34507900
[TBL] [Abstract][Full Text] [Related]
20. Multiphase computed tomography radiomics of pancreatic intraductal papillary mucinous neoplasms to predict malignancy.
Polk SL; Choi JW; McGettigan MJ; Rose T; Ahmed A; Kim J; Jiang K; Balagurunathan Y; Qi J; Farah PT; Rathi A; Permuth JB; Jeong D
World J Gastroenterol; 2020 Jun; 26(24):3458-3471. PubMed ID: 32655269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]